MedTrace Logo

Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun®

NCT02511587 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2018-05-18

Study results available
· View outcomes & findings →

Summary

FSME-Immun® is registered for application into the muscle. This study investigates if application under the skin leads to a comparable immune response.

Conditions

  • Vaccine Efficacy

Interventions

BIOLOGICAL

FSME-Immune vaccination

booster vaccination with FSME-Immune

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Ursula Wiedermann, MD, PhD · Medical University Vienna, ISPTM

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-06-30
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02511587 on ClinicalTrials.gov